Literature DB >> 9670020

Smad proteins exist as monomers in vivo and undergo homo- and hetero-oligomerization upon activation by serine/threonine kinase receptors.

M Kawabata1, H Inoue, A Hanyu, T Imamura, K Miyazono.   

Abstract

Smad proteins are signal transducers for the members of the transforming growth factor-beta (TGF-beta) superfamily. Here we show that, in the absence TGF-beta stimulation, Smads exist as monomers in vivo. Smad2 and Smad3 form homo-oligomers upon phosphorylation by the constitutively active TGF-beta type I receptor, and this oligomerization does not require Smad4. Major portions of Smad4, Smad6 and Smad7 are also present as monomers in vivo. Analysis using a cross-linking reagent suggested that the Smad2 oligomer induced by receptor activation is a trimer. Studies by gel chromatography demonstrated that the Smad2-Smad4 heteromer is not larger than the Smad2 homomer. Moreover, overexpression of Smad4 prevented Smad2 from forming a homo-oligomer. These findings suggest that Smad2 may form a homotrimer, or heterotrimers with Smad4, which are probably composed of two and one, or one and two molecules of Smad2 and Smad4, respectively, depending on the amount of each protein. Gel-mobility shift assay revealed that the Smad3 homomer and Smad3-Smad4 heteromer constitute DNA-binding complexes. Transition of the Smad proteins from monomers to oligomers is thus a critical event in the signal transduction of the TGF-beta superfamily members.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9670020      PMCID: PMC1170738          DOI: 10.1093/emboj/17.14.4056

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  50 in total

1.  Phosphorylation of Ser465 and Ser467 in the C terminus of Smad2 mediates interaction with Smad4 and is required for transforming growth factor-beta signaling.

Authors:  S Souchelnytskyi; K Tamaki; U Engström; C Wernstedt; P ten Dijke; C H Heldin
Journal:  J Biol Chem       Date:  1997-10-31       Impact factor: 5.157

2.  Homomeric interactions between type II transforming growth factor-beta receptors.

Authors:  R H Chen; R Derynck
Journal:  J Biol Chem       Date:  1994-09-09       Impact factor: 5.157

3.  Xenopus Mad proteins transduce distinct subsets of signals for the TGF beta superfamily.

Authors:  J M Graff; A Bansal; D A Melton
Journal:  Cell       Date:  1996-05-17       Impact factor: 41.582

4.  Smad6 inhibits signalling by the TGF-beta superfamily.

Authors:  T Imamura; M Takase; A Nishihara; E Oeda; J Hanai; M Kawabata; K Miyazono
Journal:  Nature       Date:  1997-10-09       Impact factor: 49.962

5.  Vascular MADs: two novel MAD-related genes selectively inducible by flow in human vascular endothelium.

Authors:  J N Topper; J Cai; Y Qiu; K R Anderson; Y Y Xu; J D Deeds; R Feeley; C J Gimeno; E A Woolf; O Tayber; G G Mays; B A Sampson; F J Schoen; M A Gimbrone; D Falb
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

6.  A structural basis for mutational inactivation of the tumour suppressor Smad4.

Authors:  Y Shi; A Hata; R S Lo; J Massagué; N P Pavletich
Journal:  Nature       Date:  1997-07-03       Impact factor: 49.962

7.  Partnership between DPC4 and SMAD proteins in TGF-beta signalling pathways.

Authors:  G Lagna; A Hata; A Hemmati-Brivanlou; J Massagué
Journal:  Nature       Date:  1996-10-31       Impact factor: 49.962

8.  Transforming growth factor beta-induced phosphorylation of Smad3 is required for growth inhibition and transcriptional induction in epithelial cells.

Authors:  X Liu; Y Sun; S N Constantinescu; E Karam; R A Weinberg; H F Lodish
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-30       Impact factor: 11.205

Review 9.  TGF-beta signalling from cell membrane to nucleus through SMAD proteins.

Authors:  C H Heldin; K Miyazono; P ten Dijke
Journal:  Nature       Date:  1997-12-04       Impact factor: 49.962

10.  GS domain mutations that constitutively activate T beta R-I, the downstream signaling component in the TGF-beta receptor complex.

Authors:  R Wieser; J L Wrana; J Massagué
Journal:  EMBO J       Date:  1995-05-15       Impact factor: 11.598

View more
  70 in total

Review 1.  Transcriptional control by the TGF-beta/Smad signaling system.

Authors:  J Massagué; D Wotton
Journal:  EMBO J       Date:  2000-04-17       Impact factor: 11.598

2.  PTGF-beta, a type beta transforming growth factor (TGF-beta) superfamily member, is a p53 target gene that inhibits tumor cell growth via TGF-beta signaling pathway.

Authors:  M Tan; Y Wang; K Guan; Y Sun
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

3.  Inactivation of smad-transforming growth factor beta signaling by Ca(2+)-calmodulin-dependent protein kinase II.

Authors:  S J Wicks; S Lui; N Abdel-Wahab; R M Mason; A Chantry
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

4.  Ligand-dependent degradation of Smad3 by a ubiquitin ligase complex of ROC1 and associated proteins.

Authors:  M Fukuchi; T Imamura; T Chiba; T Ebisawa; M Kawabata; K Tanaka; K Miyazono
Journal:  Mol Biol Cell       Date:  2001-05       Impact factor: 4.138

5.  Hgs (Hrs), a FYVE domain protein, is involved in Smad signaling through cooperation with SARA.

Authors:  S Miura; T Takeshita; H Asao; Y Kimura; K Murata; Y Sasaki; J I Hanai; H Beppu; T Tsukazaki; J L Wrana; K Miyazono; K Sugamura
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

6.  Integration of Runx and Smad regulatory signals at transcriptionally active subnuclear sites.

Authors:  Sayyed K Zaidi; Andrew J Sullivan; Andre J van Wijnen; Janet L Stein; Gary S Stein; Jane B Lian
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-11       Impact factor: 11.205

7.  Gene expression profiles identify a role for cyclooxygenase 2-dependent prostanoid generation in BMP6-induced angiogenic responses.

Authors:  Rongqin Ren; Peter C Charles; Chunlian Zhang; Yaxu Wu; Hong Wang; Cam Patterson
Journal:  Blood       Date:  2007-04-01       Impact factor: 22.113

8.  Fine-tuning BMP7 signalling in adipogenesis by UBE2O/E2-230K-mediated monoubiquitination of SMAD6.

Authors:  Xiaofei Zhang; Juan Zhang; Andreas Bauer; Long Zhang; Douglas W Selinger; Chris X Lu; Peter Ten Dijke
Journal:  EMBO J       Date:  2013-03-01       Impact factor: 11.598

9.  Antagonistic Smad transcription factors control the dauer/non-dauer switch in C. elegans.

Authors:  Donha Park; Annette Estevez; Donald L Riddle
Journal:  Development       Date:  2010-02       Impact factor: 6.868

10.  Functional heterogeneity of bone morphogenetic protein receptor-II mutants found in patients with primary pulmonary hypertension.

Authors:  Ayako Nishihara; Tetsuro Watabe; Takeshi Imamura; Kohei Miyazono
Journal:  Mol Biol Cell       Date:  2002-09       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.